TNNI3K
TYR version of PSPA with Y as phospho-acceptor
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P02786 | Y152 | Sugiyama | TFRC | sEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVENQ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P26639 | T629 | Sugiyama | TARS1 TARS | GGKWPFWLSPRQVMVVPVGPtCDEyAQKVRQQFHDAKFMAD |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P34932 | S31 | Sugiyama | HSPA4 APG2 HSPH2 | QSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGAA |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P52888 | Y576 | Sugiyama | THOP1 | VLAKVDQALHTQTDADPAEEyARLCQEILGVPATPGTNMPA |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q59H18 | S424 | Sugiyama | TNNI3K CARK | YKRPQDELPCNEYSQPGGDGsyVsVPsPLGKIKSMTKEKAD |
| Q59H18 | S427 | Sugiyama | TNNI3K CARK | PQDELPCNEYSQPGGDGsyVsVPsPLGKIKSMTKEKADILL |
| Q59H18 | S430 | Sugiyama | TNNI3K CARK | ELPCNEYSQPGGDGsyVsVPsPLGKIKSMTKEKADILLLRA |
| Q59H18 | S615 | Sugiyama | TNNI3K CARK | LLYEDGHAVVADFGESRFLQsLDEDNMtKQPGNLRWMAPEV |
| Q59H18 | T622 | Sugiyama | TNNI3K CARK | AVVADFGESRFLQsLDEDNMtKQPGNLRWMAPEVFTQCTRY |
| Q59H18 | Y390 | Sugiyama | TNNI3K CARK | ACDPSRSSGEKDEQTCLMWAyEKGHDAIVTLLKHYKRPQDE |
| Q59H18 | Y425 | Sugiyama | TNNI3K CARK | KRPQDELPCNEYSQPGGDGsyVsVPsPLGKIKSMTKEKADI |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9Y617 | Y230 | Sugiyama | PSAT1 PSA | VIVRDDLLGFALRECPsVLEyKVQAGNSSLYNTPPCFSIYV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.038514e-11 | 10.517 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.494703e-10 | 9.125 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.026220e-09 | 8.989 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.430253e-09 | 8.845 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.430253e-09 | 8.845 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.783090e-09 | 8.109 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.103821e-09 | 8.091 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.095794e-08 | 7.960 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.927619e-08 | 7.715 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.778215e-08 | 7.321 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.588930e-08 | 7.181 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.523864e-07 | 6.817 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.677510e-07 | 6.572 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.390650e-07 | 6.470 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.798309e-07 | 6.420 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.289880e-07 | 6.277 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.414756e-07 | 6.130 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.772178e-07 | 6.057 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.108792e-06 | 5.955 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.300519e-06 | 5.886 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.300519e-06 | 5.886 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.291903e-06 | 5.889 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.424222e-06 | 5.846 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.598413e-06 | 5.796 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.708568e-06 | 5.767 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.939524e-06 | 5.712 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.517840e-06 | 5.599 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.540713e-06 | 5.595 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.624873e-06 | 5.441 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.073685e-06 | 5.390 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.686678e-06 | 5.329 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.628194e-06 | 5.335 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.567863e-06 | 5.340 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.171144e-06 | 5.286 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.699400e-06 | 5.061 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.425911e-05 | 4.846 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.592268e-05 | 4.798 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.852813e-05 | 4.732 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.793579e-05 | 4.746 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.229019e-05 | 4.652 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.530598e-05 | 4.597 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.862930e-05 | 4.543 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.353682e-05 | 4.474 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.663690e-05 | 4.436 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.663690e-05 | 4.436 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.649962e-05 | 4.438 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.725545e-05 | 4.326 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.167962e-05 | 4.210 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.139261e-05 | 4.146 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.139261e-05 | 4.146 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.855576e-05 | 4.105 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.715544e-05 | 4.060 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.007483e-04 | 3.997 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.297457e-04 | 3.887 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.215505e-04 | 3.915 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.259659e-04 | 3.900 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.218014e-04 | 3.914 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.297457e-04 | 3.887 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.218014e-04 | 3.914 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.356094e-04 | 3.868 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.388025e-04 | 3.858 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.584234e-04 | 3.800 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.760297e-04 | 3.754 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.652281e-04 | 3.782 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.823782e-04 | 3.739 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.126700e-04 | 3.672 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.476171e-04 | 3.606 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.348431e-04 | 3.629 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.623996e-04 | 3.581 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.698844e-04 | 3.569 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.925008e-04 | 3.534 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.074060e-04 | 3.512 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.049310e-04 | 3.516 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.253163e-04 | 3.488 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.529771e-04 | 3.452 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.659492e-04 | 3.437 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.007351e-04 | 3.397 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.492023e-04 | 3.348 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.492023e-04 | 3.348 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.492023e-04 | 3.348 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.689701e-04 | 3.245 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.689701e-04 | 3.245 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.715963e-04 | 3.243 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.940733e-04 | 3.159 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.108095e-04 | 3.148 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.108095e-04 | 3.148 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.108095e-04 | 3.148 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.961628e-04 | 3.157 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.503945e-04 | 3.187 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.887088e-04 | 3.103 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.887088e-04 | 3.103 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.887088e-04 | 3.103 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.281331e-04 | 3.082 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.354484e-04 | 3.078 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.511356e-04 | 3.070 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.511356e-04 | 3.070 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.907561e-04 | 3.004 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.058400e-03 | 2.975 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.278592e-03 | 2.893 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.364948e-03 | 2.865 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.387029e-03 | 2.858 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.387029e-03 | 2.858 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.537232e-03 | 2.813 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.581808e-03 | 2.801 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.936708e-03 | 2.713 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.067454e-03 | 2.685 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.067454e-03 | 2.685 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.246377e-03 | 2.649 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.163470e-03 | 2.665 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.338867e-03 | 2.631 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.338867e-03 | 2.631 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.010456e-03 | 2.697 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.236062e-03 | 2.651 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.343110e-03 | 2.630 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.343110e-03 | 2.630 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.416987e-03 | 2.617 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.563673e-03 | 2.591 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.640500e-03 | 2.578 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.838487e-03 | 2.547 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.960987e-03 | 2.529 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.988897e-03 | 2.524 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.066294e-03 | 2.513 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.152972e-03 | 2.501 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.302666e-03 | 2.481 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.668470e-03 | 2.436 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 3.789931e-03 | 2.421 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.302666e-03 | 2.481 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.302666e-03 | 2.481 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 3.789931e-03 | 2.421 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.197787e-03 | 2.495 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.215784e-03 | 2.493 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.787481e-03 | 2.422 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.761483e-03 | 2.322 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.910390e-03 | 2.309 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.037985e-03 | 2.298 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.175584e-03 | 2.286 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.308602e-03 | 2.275 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.835337e-03 | 2.234 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.862967e-03 | 2.232 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.862967e-03 | 2.232 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.377786e-03 | 2.195 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.009111e-03 | 2.154 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.009111e-03 | 2.154 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.082463e-03 | 2.150 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.111689e-03 | 2.148 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.486163e-03 | 2.126 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.280462e-03 | 2.082 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.647086e-03 | 2.016 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 9.647086e-03 | 2.016 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 9.647086e-03 | 2.016 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.248225e-03 | 2.034 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.689384e-03 | 2.014 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.891722e-03 | 2.005 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.701521e-03 | 2.060 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.820373e-03 | 2.055 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.820373e-03 | 2.055 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.689384e-03 | 2.014 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.109422e-02 | 1.955 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.110672e-02 | 1.954 | 0 | 0 |
| TLR3 deficiency - HSE | R-HSA-5602410 | 1.117755e-02 | 1.952 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.141183e-02 | 1.943 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.192727e-02 | 1.923 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.222108e-02 | 1.913 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.262412e-02 | 1.899 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.265714e-02 | 1.898 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.300910e-02 | 1.886 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.309469e-02 | 1.883 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.349200e-02 | 1.870 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.429615e-02 | 1.845 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.429615e-02 | 1.845 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.486481e-02 | 1.828 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.546167e-02 | 1.811 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.595974e-02 | 1.797 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.602160e-02 | 1.795 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.644661e-02 | 1.784 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.646527e-02 | 1.783 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.663212e-02 | 1.779 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.783138e-02 | 1.749 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.783138e-02 | 1.749 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.223085e-02 | 1.653 | 0 | 0 |
| UNC93B1 deficiency - HSE | R-HSA-5602415 | 2.223085e-02 | 1.653 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.972341e-02 | 1.705 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.374608e-02 | 1.624 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.246893e-02 | 1.648 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.223085e-02 | 1.653 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.139264e-02 | 1.670 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.972341e-02 | 1.705 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.169564e-02 | 1.664 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.956136e-02 | 1.709 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.972341e-02 | 1.705 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.208092e-02 | 1.656 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.303274e-02 | 1.638 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.381476e-02 | 1.623 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.587213e-02 | 1.587 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.587213e-02 | 1.587 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.587273e-02 | 1.587 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.587273e-02 | 1.587 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.697802e-02 | 1.569 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.796531e-02 | 1.553 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.807367e-02 | 1.552 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 2.828598e-02 | 1.548 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.215631e-02 | 1.493 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.239280e-02 | 1.490 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.269079e-02 | 1.486 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.316127e-02 | 1.479 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.316127e-02 | 1.479 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.316127e-02 | 1.479 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.316127e-02 | 1.479 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.316127e-02 | 1.479 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.345994e-02 | 1.475 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.428705e-02 | 1.465 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.456907e-02 | 1.461 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.510327e-02 | 1.455 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.510327e-02 | 1.455 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.510327e-02 | 1.455 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.621878e-02 | 1.441 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.621878e-02 | 1.441 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.758260e-02 | 1.425 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.758260e-02 | 1.425 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.758260e-02 | 1.425 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.909109e-02 | 1.408 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.947246e-02 | 1.404 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.012700e-02 | 1.397 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.012700e-02 | 1.397 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.012700e-02 | 1.397 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.055532e-02 | 1.392 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.175740e-02 | 1.379 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.204055e-02 | 1.376 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.207588e-02 | 1.376 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 4.273473e-02 | 1.369 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.273473e-02 | 1.369 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.286619e-02 | 1.368 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.465887e-02 | 1.262 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.465887e-02 | 1.262 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.465887e-02 | 1.262 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.465887e-02 | 1.262 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.465887e-02 | 1.262 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.522874e-02 | 1.186 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 6.522874e-02 | 1.186 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.522874e-02 | 1.186 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.522874e-02 | 1.186 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.914636e-02 | 1.309 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 5.233027e-02 | 1.281 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.337358e-02 | 1.273 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 5.877824e-02 | 1.231 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.397016e-02 | 1.357 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.397016e-02 | 1.357 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.465887e-02 | 1.262 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 6.522874e-02 | 1.186 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.227541e-02 | 1.206 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 5.877824e-02 | 1.231 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.376502e-02 | 1.270 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.666423e-02 | 1.247 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.961691e-02 | 1.225 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.397016e-02 | 1.357 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.397016e-02 | 1.357 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.813332e-02 | 1.318 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.986550e-02 | 1.302 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.522874e-02 | 1.186 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.666423e-02 | 1.247 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.339568e-02 | 1.272 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.092085e-02 | 1.293 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.261008e-02 | 1.279 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.486055e-02 | 1.261 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.284167e-02 | 1.202 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.376502e-02 | 1.270 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.600975e-02 | 1.180 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.600975e-02 | 1.180 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.600975e-02 | 1.180 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.688849e-02 | 1.175 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.688849e-02 | 1.175 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.895542e-02 | 1.161 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.193191e-02 | 1.143 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.193191e-02 | 1.143 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.193191e-02 | 1.143 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.468304e-02 | 1.127 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 7.568106e-02 | 1.121 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 7.568106e-02 | 1.121 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.568106e-02 | 1.121 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 7.568106e-02 | 1.121 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 7.568106e-02 | 1.121 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.780831e-02 | 1.109 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.780831e-02 | 1.109 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.837141e-02 | 1.106 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.837141e-02 | 1.106 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.498387e-02 | 1.071 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.498387e-02 | 1.071 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.542115e-02 | 1.068 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.601715e-02 | 1.065 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 8.601715e-02 | 1.065 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 8.601715e-02 | 1.065 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 8.601715e-02 | 1.065 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.601715e-02 | 1.065 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.835159e-02 | 1.054 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.102481e-02 | 1.041 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.175854e-02 | 1.037 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.392060e-02 | 1.027 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 9.623830e-02 | 1.017 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 9.623830e-02 | 1.017 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.063458e-01 | 0.973 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.163408e-01 | 0.934 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.163408e-01 | 0.934 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.163408e-01 | 0.934 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.163408e-01 | 0.934 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.262247e-01 | 0.899 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.262247e-01 | 0.899 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.359986e-01 | 0.866 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.456638e-01 | 0.837 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.646727e-01 | 0.783 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.646727e-01 | 0.783 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.646727e-01 | 0.783 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.740189e-01 | 0.759 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 1.832610e-01 | 0.737 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.832610e-01 | 0.737 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.239820e-01 | 0.907 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.782686e-01 | 0.749 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.223177e-01 | 0.913 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.552214e-01 | 0.809 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 1.205185e-01 | 0.919 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.740189e-01 | 0.759 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.063458e-01 | 0.973 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.359986e-01 | 0.866 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.456638e-01 | 0.837 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.166006e-01 | 0.933 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.085538e-01 | 0.964 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.166006e-01 | 0.933 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.166006e-01 | 0.933 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.163408e-01 | 0.934 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.809394e-01 | 0.742 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 1.359986e-01 | 0.866 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 1.740189e-01 | 0.759 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.390650e-01 | 0.857 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.022020e-01 | 0.991 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.809394e-01 | 0.742 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.623830e-02 | 1.017 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.646727e-01 | 0.783 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.646727e-01 | 0.783 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.740189e-01 | 0.759 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.868501e-02 | 1.006 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.663192e-01 | 0.779 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.132820e-01 | 0.946 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 1.646727e-01 | 0.783 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 1.109081e-01 | 0.955 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 1.068002e-01 | 0.971 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.584352e-01 | 0.800 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.057533e-01 | 0.976 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.868501e-02 | 1.006 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.868501e-02 | 1.006 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.359986e-01 | 0.866 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.740189e-01 | 0.759 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.239820e-01 | 0.907 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.536958e-01 | 0.813 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.536958e-01 | 0.813 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.314729e-01 | 0.881 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.352569e-01 | 0.869 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.646727e-01 | 0.783 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.646727e-01 | 0.783 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.646727e-01 | 0.783 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.379695e-01 | 0.860 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.359986e-01 | 0.866 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 1.646727e-01 | 0.783 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 1.740189e-01 | 0.759 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.129537e-01 | 0.947 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.147967e-01 | 0.940 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.646727e-01 | 0.783 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.646727e-01 | 0.783 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.646727e-01 | 0.783 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 1.832610e-01 | 0.737 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.262247e-01 | 0.899 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.093376e-01 | 0.961 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.661250e-02 | 1.015 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.157863e-01 | 0.936 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.838470e-01 | 0.736 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.456638e-01 | 0.837 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.456638e-01 | 0.837 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.022020e-01 | 0.991 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.406067e-01 | 0.852 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.262247e-01 | 0.899 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.832610e-01 | 0.737 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.004014e-01 | 0.998 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.893560e-01 | 0.723 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.623684e-01 | 0.789 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.222288e-01 | 0.913 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.354820e-01 | 0.868 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 1.057533e-01 | 0.976 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.352569e-01 | 0.869 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.649450e-01 | 0.783 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.329446e-01 | 0.876 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.300445e-01 | 0.886 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.782686e-01 | 0.749 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.782686e-01 | 0.749 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.782686e-01 | 0.749 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.782686e-01 | 0.749 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.782686e-01 | 0.749 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.279211e-01 | 0.893 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.694226e-02 | 1.013 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.782686e-01 | 0.749 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.282923e-01 | 0.892 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.903459e-01 | 0.720 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.903459e-01 | 0.720 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.924003e-01 | 0.716 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 1.924003e-01 | 0.716 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.924003e-01 | 0.716 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.924003e-01 | 0.716 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.924003e-01 | 0.716 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.924003e-01 | 0.716 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.924003e-01 | 0.716 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.924003e-01 | 0.716 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.943963e-01 | 0.711 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.007306e-01 | 0.697 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.014379e-01 | 0.696 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.014379e-01 | 0.696 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.014379e-01 | 0.696 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.020657e-01 | 0.695 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.025295e-01 | 0.694 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.035997e-01 | 0.691 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.103749e-01 | 0.677 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.103749e-01 | 0.677 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.103749e-01 | 0.677 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.103749e-01 | 0.677 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.103749e-01 | 0.677 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 2.122634e-01 | 0.673 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.189051e-01 | 0.660 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.189051e-01 | 0.660 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.189051e-01 | 0.660 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 2.192124e-01 | 0.659 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.192124e-01 | 0.659 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.192124e-01 | 0.659 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.230176e-01 | 0.652 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.230176e-01 | 0.652 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.239370e-01 | 0.650 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.279516e-01 | 0.642 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.279516e-01 | 0.642 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.279516e-01 | 0.642 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.279516e-01 | 0.642 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.298213e-01 | 0.639 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.312604e-01 | 0.636 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.365935e-01 | 0.626 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.365935e-01 | 0.626 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.365935e-01 | 0.626 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.365935e-01 | 0.626 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.395227e-01 | 0.621 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.395227e-01 | 0.621 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.436595e-01 | 0.613 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.436595e-01 | 0.613 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.451392e-01 | 0.611 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 2.451392e-01 | 0.611 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.451392e-01 | 0.611 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.451392e-01 | 0.611 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.519417e-01 | 0.599 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.535897e-01 | 0.596 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.602314e-01 | 0.585 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.619462e-01 | 0.582 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.619462e-01 | 0.582 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.619462e-01 | 0.582 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.643776e-01 | 0.578 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 2.702096e-01 | 0.568 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.702096e-01 | 0.568 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.702096e-01 | 0.568 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.702096e-01 | 0.568 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.702096e-01 | 0.568 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.702096e-01 | 0.568 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.702096e-01 | 0.568 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.702096e-01 | 0.568 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.717083e-01 | 0.566 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.768158e-01 | 0.558 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.768158e-01 | 0.558 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.783810e-01 | 0.555 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.783810e-01 | 0.555 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.783810e-01 | 0.555 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.864614e-01 | 0.543 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.864614e-01 | 0.543 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.864614e-01 | 0.543 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 2.864614e-01 | 0.543 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.892426e-01 | 0.539 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.944518e-01 | 0.531 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.944518e-01 | 0.531 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.944518e-01 | 0.531 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.944518e-01 | 0.531 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.944518e-01 | 0.531 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.016449e-01 | 0.521 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.023532e-01 | 0.519 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.023532e-01 | 0.519 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.024075e-01 | 0.519 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.057715e-01 | 0.515 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.098937e-01 | 0.509 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.101667e-01 | 0.508 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.101667e-01 | 0.508 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.101667e-01 | 0.508 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.101667e-01 | 0.508 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.121606e-01 | 0.506 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.178931e-01 | 0.498 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.178931e-01 | 0.498 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.178931e-01 | 0.498 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.178931e-01 | 0.498 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.178931e-01 | 0.498 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.181229e-01 | 0.497 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 3.204644e-01 | 0.494 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 3.222292e-01 | 0.492 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.235236e-01 | 0.490 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.255334e-01 | 0.487 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.255334e-01 | 0.487 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 3.276474e-01 | 0.485 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.330886e-01 | 0.477 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.330886e-01 | 0.477 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.330886e-01 | 0.477 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.345102e-01 | 0.476 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.385900e-01 | 0.470 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.405597e-01 | 0.468 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.405597e-01 | 0.468 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.426623e-01 | 0.465 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.479475e-01 | 0.458 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.479475e-01 | 0.458 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.479475e-01 | 0.458 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.479475e-01 | 0.458 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.479475e-01 | 0.458 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.507829e-01 | 0.455 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.552530e-01 | 0.449 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.552530e-01 | 0.449 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.552530e-01 | 0.449 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.552530e-01 | 0.449 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.552530e-01 | 0.449 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.552530e-01 | 0.449 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 3.601940e-01 | 0.443 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.624770e-01 | 0.441 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.624770e-01 | 0.441 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.624770e-01 | 0.441 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.624770e-01 | 0.441 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 3.624770e-01 | 0.441 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.628993e-01 | 0.440 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 3.662858e-01 | 0.436 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 3.662858e-01 | 0.436 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.683953e-01 | 0.434 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.696206e-01 | 0.432 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.696206e-01 | 0.432 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.696206e-01 | 0.432 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.766846e-01 | 0.424 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.766846e-01 | 0.424 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.766846e-01 | 0.424 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.766846e-01 | 0.424 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.766846e-01 | 0.424 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.766846e-01 | 0.424 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.836699e-01 | 0.416 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.836699e-01 | 0.416 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.836699e-01 | 0.416 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.836699e-01 | 0.416 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.836699e-01 | 0.416 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.836699e-01 | 0.416 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.836699e-01 | 0.416 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.836699e-01 | 0.416 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.875248e-01 | 0.412 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.905773e-01 | 0.408 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.905773e-01 | 0.408 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.905773e-01 | 0.408 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.905773e-01 | 0.408 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.905773e-01 | 0.408 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 3.905773e-01 | 0.408 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.908275e-01 | 0.408 | 0 | 0 |
| Translation | R-HSA-72766 | 3.943602e-01 | 0.404 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.041620e-01 | 0.393 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.041620e-01 | 0.393 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.041620e-01 | 0.393 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.041620e-01 | 0.393 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.041620e-01 | 0.393 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.041620e-01 | 0.393 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.041620e-01 | 0.393 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.041620e-01 | 0.393 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.108410e-01 | 0.386 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.108410e-01 | 0.386 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.108410e-01 | 0.386 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.108410e-01 | 0.386 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.108410e-01 | 0.386 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.108410e-01 | 0.386 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.108410e-01 | 0.386 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.108410e-01 | 0.386 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.108410e-01 | 0.386 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.108410e-01 | 0.386 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.174455e-01 | 0.379 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.174455e-01 | 0.379 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.174455e-01 | 0.379 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.239764e-01 | 0.373 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.239764e-01 | 0.373 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.239764e-01 | 0.373 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.239764e-01 | 0.373 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.239764e-01 | 0.373 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.239764e-01 | 0.373 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.239764e-01 | 0.373 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.239764e-01 | 0.373 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.304345e-01 | 0.366 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.304345e-01 | 0.366 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.312278e-01 | 0.365 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.368205e-01 | 0.360 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.368205e-01 | 0.360 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.368205e-01 | 0.360 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.431354e-01 | 0.353 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.431354e-01 | 0.353 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.431354e-01 | 0.353 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.493798e-01 | 0.347 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.493798e-01 | 0.347 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.493798e-01 | 0.347 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.493798e-01 | 0.347 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.493798e-01 | 0.347 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.493798e-01 | 0.347 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.493798e-01 | 0.347 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.493798e-01 | 0.347 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.501278e-01 | 0.347 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.555546e-01 | 0.341 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.555546e-01 | 0.341 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.555546e-01 | 0.341 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.562001e-01 | 0.341 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.616605e-01 | 0.336 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.616605e-01 | 0.336 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.616605e-01 | 0.336 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.658946e-01 | 0.332 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.673223e-01 | 0.330 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.736688e-01 | 0.325 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.736688e-01 | 0.325 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.746623e-01 | 0.324 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.795727e-01 | 0.319 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.854107e-01 | 0.314 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.854107e-01 | 0.314 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.854107e-01 | 0.314 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.891584e-01 | 0.311 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.911836e-01 | 0.309 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.911836e-01 | 0.309 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.911836e-01 | 0.309 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.911836e-01 | 0.309 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.963127e-01 | 0.304 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.968921e-01 | 0.304 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.968921e-01 | 0.304 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.968921e-01 | 0.304 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.968921e-01 | 0.304 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.998660e-01 | 0.301 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.025369e-01 | 0.299 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 5.025369e-01 | 0.299 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.045587e-01 | 0.297 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.081187e-01 | 0.294 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.081187e-01 | 0.294 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.136382e-01 | 0.289 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.136382e-01 | 0.289 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.136382e-01 | 0.289 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.139188e-01 | 0.289 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.139188e-01 | 0.289 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 5.190961e-01 | 0.285 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.190961e-01 | 0.285 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 5.190961e-01 | 0.285 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.244931e-01 | 0.280 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.298298e-01 | 0.276 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.298298e-01 | 0.276 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 5.351070e-01 | 0.272 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.351070e-01 | 0.272 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.351070e-01 | 0.272 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.378807e-01 | 0.269 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.396388e-01 | 0.268 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.403253e-01 | 0.267 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.403253e-01 | 0.267 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.403253e-01 | 0.267 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.403253e-01 | 0.267 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.454853e-01 | 0.263 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.454853e-01 | 0.263 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.454853e-01 | 0.263 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.454853e-01 | 0.263 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.454853e-01 | 0.263 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.454853e-01 | 0.263 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.505877e-01 | 0.259 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.505877e-01 | 0.259 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 5.577098e-01 | 0.254 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.606223e-01 | 0.251 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.606223e-01 | 0.251 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.620643e-01 | 0.250 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.674817e-01 | 0.246 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.704340e-01 | 0.244 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.706857e-01 | 0.244 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.752578e-01 | 0.240 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.752578e-01 | 0.240 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 5.847445e-01 | 0.233 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.847445e-01 | 0.233 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.847445e-01 | 0.233 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.847445e-01 | 0.233 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.894085e-01 | 0.230 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.894085e-01 | 0.230 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.894085e-01 | 0.230 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 5.894085e-01 | 0.230 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.940204e-01 | 0.226 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.940204e-01 | 0.226 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.940204e-01 | 0.226 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.957007e-01 | 0.225 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.985808e-01 | 0.223 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.985808e-01 | 0.223 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.013917e-01 | 0.221 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.017826e-01 | 0.221 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.030902e-01 | 0.220 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.075493e-01 | 0.216 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.119585e-01 | 0.213 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.206298e-01 | 0.207 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 6.206298e-01 | 0.207 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.206298e-01 | 0.207 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.206298e-01 | 0.207 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.206298e-01 | 0.207 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.206298e-01 | 0.207 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.206298e-01 | 0.207 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 6.206972e-01 | 0.207 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.300956e-01 | 0.201 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.311620e-01 | 0.200 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.332766e-01 | 0.198 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.373983e-01 | 0.196 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.373983e-01 | 0.196 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.414739e-01 | 0.193 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.414739e-01 | 0.193 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.494891e-01 | 0.187 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.494891e-01 | 0.187 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.534296e-01 | 0.185 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.534296e-01 | 0.185 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.534296e-01 | 0.185 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.534361e-01 | 0.185 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.641678e-01 | 0.178 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.724808e-01 | 0.172 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.834078e-01 | 0.165 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.869690e-01 | 0.163 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.904903e-01 | 0.161 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.974152e-01 | 0.157 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.008197e-01 | 0.154 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 7.041860e-01 | 0.152 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.140607e-01 | 0.146 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.140607e-01 | 0.146 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.172789e-01 | 0.144 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.204610e-01 | 0.142 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.204610e-01 | 0.142 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.207755e-01 | 0.142 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.328373e-01 | 0.135 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.358452e-01 | 0.133 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.359591e-01 | 0.133 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.388195e-01 | 0.131 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.446685e-01 | 0.128 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.531987e-01 | 0.123 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.552664e-01 | 0.122 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 7.569921e-01 | 0.121 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.587274e-01 | 0.120 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.691706e-01 | 0.114 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 7.711002e-01 | 0.113 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.720162e-01 | 0.112 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.745852e-01 | 0.111 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.796374e-01 | 0.108 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.805395e-01 | 0.108 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.821210e-01 | 0.107 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.821210e-01 | 0.107 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.821210e-01 | 0.107 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.894062e-01 | 0.103 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.941279e-01 | 0.100 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.941279e-01 | 0.100 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.941279e-01 | 0.100 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.987443e-01 | 0.098 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.068475e-01 | 0.093 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 8.098399e-01 | 0.092 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 8.119849e-01 | 0.090 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.165652e-01 | 0.088 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.212592e-01 | 0.086 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.223542e-01 | 0.085 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.263409e-01 | 0.083 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.345157e-01 | 0.079 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.359226e-01 | 0.078 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.396064e-01 | 0.076 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.429880e-01 | 0.074 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.467290e-01 | 0.072 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.484599e-01 | 0.071 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.535369e-01 | 0.069 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.551045e-01 | 0.068 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.551914e-01 | 0.068 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.551914e-01 | 0.068 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.551914e-01 | 0.068 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.568273e-01 | 0.067 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.584448e-01 | 0.066 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.584448e-01 | 0.066 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.616255e-01 | 0.065 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.616255e-01 | 0.065 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.616255e-01 | 0.065 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 8.616255e-01 | 0.065 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.709075e-01 | 0.060 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.743233e-01 | 0.058 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.819860e-01 | 0.055 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.819860e-01 | 0.055 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.846404e-01 | 0.053 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.859452e-01 | 0.053 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.885110e-01 | 0.051 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.922524e-01 | 0.050 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.038450e-01 | 0.044 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.070744e-01 | 0.042 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.161296e-01 | 0.038 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.189486e-01 | 0.037 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.210246e-01 | 0.036 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.225611e-01 | 0.035 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.411096e-01 | 0.026 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.424392e-01 | 0.026 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.468620e-01 | 0.024 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.470945e-01 | 0.024 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.515041e-01 | 0.022 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.600723e-01 | 0.018 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.714046e-01 | 0.013 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.834913e-01 | 0.007 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.867328e-01 | 0.006 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.873299e-01 | 0.006 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.923715e-01 | 0.003 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.939455e-01 | 0.003 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.956212e-01 | 0.002 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.980114e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.988074e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.993437e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.998841e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999766e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | 8.869482e-10 | 9.052 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.365636e-09 | 8.626 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.265700e-09 | 8.486 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.425232e-08 | 7.615 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.432692e-08 | 7.353 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.909858e-08 | 7.228 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.503958e-07 | 6.601 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.006742e-07 | 6.300 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.702766e-07 | 6.244 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.811892e-06 | 5.742 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.811892e-06 | 5.742 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.910307e-06 | 5.719 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.575262e-06 | 5.803 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.256084e-06 | 5.647 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.193248e-06 | 5.659 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.641600e-06 | 5.578 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.412403e-06 | 5.618 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.641600e-06 | 5.578 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.122897e-06 | 5.385 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.683819e-06 | 5.329 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.668210e-06 | 5.247 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.069701e-06 | 5.217 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.241618e-06 | 5.084 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.241618e-06 | 5.084 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.473476e-06 | 5.072 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.878946e-06 | 5.005 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.201030e-05 | 4.920 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.551907e-05 | 4.809 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.002644e-05 | 4.698 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.232257e-05 | 4.651 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.303189e-05 | 4.638 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.482041e-05 | 4.605 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.773937e-05 | 4.557 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.925195e-05 | 4.534 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.779950e-05 | 4.423 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.779950e-05 | 4.423 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.998853e-05 | 4.398 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.243689e-05 | 4.372 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.599574e-05 | 4.337 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.863362e-05 | 4.313 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.894744e-05 | 4.310 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.390388e-05 | 4.268 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.549733e-05 | 4.256 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.652651e-05 | 4.248 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.308589e-05 | 4.200 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.509372e-05 | 4.186 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.509372e-05 | 4.186 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.302027e-05 | 4.201 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.675285e-05 | 4.176 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.652135e-05 | 4.063 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.129863e-04 | 3.947 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.403296e-04 | 3.853 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.474940e-04 | 3.831 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.508099e-04 | 3.822 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.910297e-04 | 3.719 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.961203e-04 | 3.707 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.991668e-04 | 3.701 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.334201e-04 | 3.632 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.203167e-04 | 3.657 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.310777e-04 | 3.636 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.479335e-04 | 3.606 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.507453e-04 | 3.601 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.649846e-04 | 3.577 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.774355e-04 | 3.557 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.857689e-04 | 3.544 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.030435e-04 | 3.518 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.343931e-04 | 3.476 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.389507e-04 | 3.470 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.412611e-04 | 3.467 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.872923e-04 | 3.412 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.872923e-04 | 3.412 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.872923e-04 | 3.412 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.037355e-04 | 3.394 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.061582e-04 | 3.391 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.945126e-04 | 3.306 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.656560e-04 | 3.332 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.257191e-04 | 3.279 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.257191e-04 | 3.279 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.297430e-04 | 3.276 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.332534e-04 | 3.273 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.873824e-04 | 3.231 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.565700e-04 | 3.254 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.565700e-04 | 3.254 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.016198e-04 | 3.221 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.540124e-04 | 3.184 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.540124e-04 | 3.184 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.687547e-04 | 3.175 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.701638e-04 | 3.113 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.794926e-04 | 3.108 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.030480e-04 | 3.095 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.826356e-04 | 3.054 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.915471e-04 | 3.004 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.006905e-03 | 2.997 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.007679e-03 | 2.997 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.069338e-03 | 2.971 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.143721e-03 | 2.942 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.216258e-03 | 2.915 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.217071e-03 | 2.915 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.280435e-03 | 2.893 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.392198e-03 | 2.856 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 1.448385e-03 | 2.839 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.676466e-03 | 2.776 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.864615e-03 | 2.729 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.879552e-03 | 2.726 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.935297e-03 | 2.713 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.940506e-03 | 2.712 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.042984e-03 | 2.690 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.072067e-03 | 2.684 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.398682e-03 | 2.620 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.274557e-03 | 2.643 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.231256e-03 | 2.651 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.199635e-03 | 2.658 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.274557e-03 | 2.643 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.271395e-03 | 2.644 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.199635e-03 | 2.658 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.231256e-03 | 2.651 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.479265e-03 | 2.606 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.798205e-03 | 2.553 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.952475e-03 | 2.530 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.119411e-03 | 2.506 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.147508e-03 | 2.502 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.154936e-03 | 2.501 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.363034e-03 | 2.473 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.363034e-03 | 2.473 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.363034e-03 | 2.473 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.407593e-03 | 2.468 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.525061e-03 | 2.453 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.587871e-03 | 2.445 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.628586e-03 | 2.440 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.202629e-03 | 2.376 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.813028e-03 | 2.419 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.328348e-03 | 2.364 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.813028e-03 | 2.419 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.202629e-03 | 2.376 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.421258e-03 | 2.354 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.424019e-03 | 2.354 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.559520e-03 | 2.341 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.559520e-03 | 2.341 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.615555e-03 | 2.336 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.842839e-03 | 2.315 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.842839e-03 | 2.315 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.417894e-03 | 2.266 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.419920e-03 | 2.266 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.456353e-03 | 2.263 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.588735e-03 | 2.253 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 5.808334e-03 | 2.236 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.566841e-03 | 2.183 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.713996e-03 | 2.173 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.933103e-03 | 2.101 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.042995e-03 | 2.152 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.652054e-03 | 2.177 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.736549e-03 | 2.111 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.933103e-03 | 2.101 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.713996e-03 | 2.173 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.088750e-03 | 2.149 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.933103e-03 | 2.101 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.736549e-03 | 2.111 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.171570e-03 | 2.088 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.171570e-03 | 2.088 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.618751e-03 | 2.065 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.093189e-02 | 1.961 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.093189e-02 | 1.961 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.093189e-02 | 1.961 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.093189e-02 | 1.961 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.243895e-03 | 2.034 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 9.243895e-03 | 2.034 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.064424e-02 | 1.973 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.079439e-02 | 1.967 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.980033e-03 | 2.047 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.403134e-03 | 2.027 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.711226e-03 | 2.013 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.439198e-03 | 2.025 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 9.439198e-03 | 2.025 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.213440e-03 | 2.036 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.079439e-02 | 1.967 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.064424e-02 | 1.973 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 9.243895e-03 | 2.034 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 9.243895e-03 | 2.034 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.079439e-02 | 1.967 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.439198e-03 | 2.025 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.079439e-02 | 1.967 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.439198e-03 | 2.025 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.079439e-02 | 1.967 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.801207e-03 | 2.055 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.151198e-02 | 1.939 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.179177e-02 | 1.928 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.179177e-02 | 1.928 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.213206e-02 | 1.916 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.213206e-02 | 1.916 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.225645e-02 | 1.912 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.236646e-02 | 1.908 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.246858e-02 | 1.904 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.246858e-02 | 1.904 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.251506e-02 | 1.903 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.273030e-02 | 1.895 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.302797e-02 | 1.885 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.325941e-02 | 1.877 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.337115e-02 | 1.874 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.347793e-02 | 1.870 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.370528e-02 | 1.863 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.370528e-02 | 1.863 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.380234e-02 | 1.860 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.382666e-02 | 1.859 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.382666e-02 | 1.859 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.451969e-02 | 1.838 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.536189e-02 | 1.814 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.550606e-02 | 1.809 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.174494e-02 | 1.663 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.891733e-02 | 1.723 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.081228e-02 | 1.682 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.120632e-02 | 1.674 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.883096e-02 | 1.725 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.709989e-02 | 1.767 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.709989e-02 | 1.767 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.638696e-02 | 1.786 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.729544e-02 | 1.762 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.081228e-02 | 1.682 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.081228e-02 | 1.682 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.729544e-02 | 1.762 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.001544e-02 | 1.699 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.709989e-02 | 1.767 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.672823e-02 | 1.777 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.734448e-02 | 1.761 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 2.047205e-02 | 1.689 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.932854e-02 | 1.714 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.081228e-02 | 1.682 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.891733e-02 | 1.723 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.709989e-02 | 1.767 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.709989e-02 | 1.767 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.107704e-02 | 1.676 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.175342e-02 | 1.662 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.672823e-02 | 1.777 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.216581e-02 | 1.654 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.225345e-02 | 1.653 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.225345e-02 | 1.653 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.225345e-02 | 1.653 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.225345e-02 | 1.653 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.225345e-02 | 1.653 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.225345e-02 | 1.653 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.278286e-02 | 1.642 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.278286e-02 | 1.642 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.291273e-02 | 1.640 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.299981e-02 | 1.638 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.332838e-02 | 1.632 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.442747e-02 | 1.612 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.443109e-02 | 1.612 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.445219e-02 | 1.612 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.482720e-02 | 1.605 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.482720e-02 | 1.605 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.482720e-02 | 1.605 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.518582e-02 | 1.599 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.524483e-02 | 1.598 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.556157e-02 | 1.592 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 2.671980e-02 | 1.573 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.687626e-02 | 1.571 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.694347e-02 | 1.570 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.694347e-02 | 1.570 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.694347e-02 | 1.570 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.694347e-02 | 1.570 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.694347e-02 | 1.570 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 2.771513e-02 | 1.557 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.774966e-02 | 1.557 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.790573e-02 | 1.554 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.244044e-02 | 1.489 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.244044e-02 | 1.489 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.301965e-02 | 1.366 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.301965e-02 | 1.366 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.301965e-02 | 1.366 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.370606e-02 | 1.472 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.370606e-02 | 1.472 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.854196e-02 | 1.414 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.854196e-02 | 1.414 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.943944e-02 | 1.531 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.797373e-02 | 1.421 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.981493e-02 | 1.400 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.954566e-02 | 1.403 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.275935e-02 | 1.369 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.138466e-02 | 1.503 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.032495e-02 | 1.518 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.307534e-02 | 1.480 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.912988e-02 | 1.536 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.609239e-02 | 1.443 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.064983e-02 | 1.514 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.912988e-02 | 1.536 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.888694e-02 | 1.539 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 2.912988e-02 | 1.536 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.596709e-02 | 1.444 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.301965e-02 | 1.366 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 2.912988e-02 | 1.536 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.105312e-02 | 1.387 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.900074e-02 | 1.409 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.533691e-02 | 1.452 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.498743e-02 | 1.456 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.162923e-02 | 1.500 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.122608e-02 | 1.505 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.503353e-02 | 1.456 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.981493e-02 | 1.400 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.105312e-02 | 1.387 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.657446e-02 | 1.437 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.370606e-02 | 1.472 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.901102e-02 | 1.409 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.138466e-02 | 1.503 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.138466e-02 | 1.503 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 4.105312e-02 | 1.387 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.402352e-02 | 1.468 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.326677e-02 | 1.364 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.328782e-02 | 1.364 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.362425e-02 | 1.360 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.362425e-02 | 1.360 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.362425e-02 | 1.360 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.362425e-02 | 1.360 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.420582e-02 | 1.355 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.625375e-02 | 1.335 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.625375e-02 | 1.335 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.625375e-02 | 1.335 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.625375e-02 | 1.335 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.663216e-02 | 1.331 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.841985e-02 | 1.315 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.894006e-02 | 1.310 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.894006e-02 | 1.310 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.058250e-02 | 1.296 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.110108e-02 | 1.292 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.168164e-02 | 1.287 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.168164e-02 | 1.287 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.168164e-02 | 1.287 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.168164e-02 | 1.287 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.168164e-02 | 1.287 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.168164e-02 | 1.287 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.222510e-02 | 1.282 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.348384e-02 | 1.272 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.348384e-02 | 1.272 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.348384e-02 | 1.272 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.348384e-02 | 1.272 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 5.503562e-02 | 1.259 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.558688e-02 | 1.255 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.558688e-02 | 1.255 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.730569e-02 | 1.242 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.732455e-02 | 1.242 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.732455e-02 | 1.242 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.904954e-02 | 1.229 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.904954e-02 | 1.229 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.022294e-02 | 1.220 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.022294e-02 | 1.220 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.022294e-02 | 1.220 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.022294e-02 | 1.220 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.081823e-02 | 1.216 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.102022e-02 | 1.215 | 0 | 0 |
| Translation | R-HSA-72766 | 6.191625e-02 | 1.208 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 6.202835e-02 | 1.207 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 6.202835e-02 | 1.207 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 6.383425e-02 | 1.195 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.383425e-02 | 1.195 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 6.383425e-02 | 1.195 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.383425e-02 | 1.195 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 6.383425e-02 | 1.195 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.383425e-02 | 1.195 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.383425e-02 | 1.195 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.442929e-02 | 1.191 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.627125e-02 | 1.179 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.419862e-02 | 1.075 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 8.419862e-02 | 1.075 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 8.419862e-02 | 1.075 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.041225e-01 | 0.982 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 1.041225e-01 | 0.982 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.041225e-01 | 0.982 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.139221e-01 | 0.943 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.139221e-01 | 0.943 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.139221e-01 | 0.943 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.236152e-01 | 0.908 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.236152e-01 | 0.908 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.332029e-01 | 0.875 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.332029e-01 | 0.875 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.332029e-01 | 0.875 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.860140e-02 | 1.105 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.195589e-01 | 0.922 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.195589e-01 | 0.922 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.195092e-01 | 0.923 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.124536e-01 | 0.949 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.332029e-01 | 0.875 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.169696e-02 | 1.038 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.860140e-02 | 1.105 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 7.407210e-02 | 1.130 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 7.407210e-02 | 1.130 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.041225e-01 | 0.982 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.860140e-02 | 1.105 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.846751e-02 | 1.007 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.419862e-02 | 1.075 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.088754e-01 | 0.963 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.506467e-02 | 1.022 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 8.419862e-02 | 1.075 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 8.419862e-02 | 1.075 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.236152e-01 | 0.908 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.332029e-01 | 0.875 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.181655e-02 | 1.087 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.846751e-02 | 1.007 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.159689e-01 | 0.936 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.542750e-02 | 1.122 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.088754e-01 | 0.963 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.236152e-01 | 0.908 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.159689e-01 | 0.936 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.181655e-02 | 1.087 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.139221e-01 | 0.943 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.124073e-01 | 0.949 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 1.055652e-01 | 0.976 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.836556e-02 | 1.054 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.124073e-01 | 0.949 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 1.041225e-01 | 0.982 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.139221e-01 | 0.943 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.332029e-01 | 0.875 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.332029e-01 | 0.875 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.506467e-02 | 1.022 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.302379e-01 | 0.885 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.597400e-02 | 1.066 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.268202e-01 | 0.897 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.181655e-02 | 1.087 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.507168e-02 | 1.070 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.387695e-02 | 1.131 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.101386e-01 | 0.958 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.583672e-02 | 1.120 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.061212e-01 | 0.974 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.165102e-02 | 1.088 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.002697e-02 | 1.155 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.419862e-02 | 1.075 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.419862e-02 | 1.075 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.421501e-02 | 1.026 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 9.421501e-02 | 1.026 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.236152e-01 | 0.908 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.506467e-02 | 1.022 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.231763e-01 | 0.909 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.560002e-02 | 1.068 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.265774e-02 | 1.139 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.147873e-01 | 0.940 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.267247e-01 | 0.897 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.011906e-01 | 0.995 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.332029e-01 | 0.875 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.860140e-02 | 1.105 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.832805e-02 | 1.106 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.194029e-02 | 1.143 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.116999e-01 | 0.952 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.236152e-01 | 0.908 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.920868e-02 | 1.160 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.302379e-01 | 0.885 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.836556e-02 | 1.054 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.116999e-01 | 0.952 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.411960e-02 | 1.130 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.159689e-01 | 0.936 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 1.195589e-01 | 0.922 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.139221e-01 | 0.943 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.236152e-01 | 0.908 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 1.019043e-01 | 0.992 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.169696e-02 | 1.038 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.055652e-01 | 0.976 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.139221e-01 | 0.943 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.817103e-02 | 1.008 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.171304e-01 | 0.931 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.967191e-02 | 1.001 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.124073e-01 | 0.949 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.387695e-02 | 1.131 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.920868e-02 | 1.160 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.081440e-01 | 0.966 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.806746e-02 | 1.055 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.018235e-02 | 1.045 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.950571e-02 | 1.048 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.169696e-02 | 1.038 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.340912e-01 | 0.873 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.341833e-01 | 0.872 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.379005e-01 | 0.860 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 1.379005e-01 | 0.860 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.416402e-01 | 0.849 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.416402e-01 | 0.849 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.419361e-01 | 0.848 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.419361e-01 | 0.848 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.426862e-01 | 0.846 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 1.426862e-01 | 0.846 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.426862e-01 | 0.846 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.426862e-01 | 0.846 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.426862e-01 | 0.846 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.441417e-01 | 0.841 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.454016e-01 | 0.837 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.454016e-01 | 0.837 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.491836e-01 | 0.826 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.492576e-01 | 0.826 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.492576e-01 | 0.826 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 1.520664e-01 | 0.818 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.529854e-01 | 0.815 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.547224e-01 | 0.810 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.568062e-01 | 0.805 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.568062e-01 | 0.805 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.568062e-01 | 0.805 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.568062e-01 | 0.805 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.570396e-01 | 0.804 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.599520e-01 | 0.796 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 1.606450e-01 | 0.794 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.606450e-01 | 0.794 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.613445e-01 | 0.792 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.613445e-01 | 0.792 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.613445e-01 | 0.792 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.613445e-01 | 0.792 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.613445e-01 | 0.792 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.613445e-01 | 0.792 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.613445e-01 | 0.792 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.613445e-01 | 0.792 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.613445e-01 | 0.792 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.613445e-01 | 0.792 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.622965e-01 | 0.790 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 1.645010e-01 | 0.784 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 1.649449e-01 | 0.783 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.702800e-01 | 0.769 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.705217e-01 | 0.768 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.705217e-01 | 0.768 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.705217e-01 | 0.768 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.723379e-01 | 0.764 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.761641e-01 | 0.754 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.781061e-01 | 0.749 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.783747e-01 | 0.749 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.783747e-01 | 0.749 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.795990e-01 | 0.746 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 1.795990e-01 | 0.746 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.795990e-01 | 0.746 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.795990e-01 | 0.746 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.795990e-01 | 0.746 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 1.795990e-01 | 0.746 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.795990e-01 | 0.746 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.800808e-01 | 0.745 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 1.840108e-01 | 0.735 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.865735e-01 | 0.729 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.871350e-01 | 0.728 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 1.879532e-01 | 0.726 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.879532e-01 | 0.726 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.879532e-01 | 0.726 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.885775e-01 | 0.725 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.885775e-01 | 0.725 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.885775e-01 | 0.725 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.885775e-01 | 0.725 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 1.885775e-01 | 0.725 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.885775e-01 | 0.725 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.885775e-01 | 0.725 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.885775e-01 | 0.725 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 1.885775e-01 | 0.725 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.885775e-01 | 0.725 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.885775e-01 | 0.725 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.919074e-01 | 0.717 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.919074e-01 | 0.717 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.974583e-01 | 0.705 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 1.974583e-01 | 0.705 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.974583e-01 | 0.705 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 1.974583e-01 | 0.705 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 1.974583e-01 | 0.705 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.004502e-01 | 0.698 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.036549e-01 | 0.691 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.038331e-01 | 0.691 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.062424e-01 | 0.686 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.062424e-01 | 0.686 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.062424e-01 | 0.686 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.062424e-01 | 0.686 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 2.062424e-01 | 0.686 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.118295e-01 | 0.674 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.145639e-01 | 0.668 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 2.149310e-01 | 0.668 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.149310e-01 | 0.668 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.149310e-01 | 0.668 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 2.149310e-01 | 0.668 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.149310e-01 | 0.668 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.158394e-01 | 0.666 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.158394e-01 | 0.666 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.158394e-01 | 0.666 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 2.158394e-01 | 0.666 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 2.198563e-01 | 0.658 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.219248e-01 | 0.654 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.235249e-01 | 0.651 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.235249e-01 | 0.651 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.235249e-01 | 0.651 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 2.235249e-01 | 0.651 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.288866e-01 | 0.640 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.320254e-01 | 0.634 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.320254e-01 | 0.634 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.320254e-01 | 0.634 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.320254e-01 | 0.634 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.320254e-01 | 0.634 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.320254e-01 | 0.634 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.320254e-01 | 0.634 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.359812e-01 | 0.627 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.375605e-01 | 0.624 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.375605e-01 | 0.624 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 2.404332e-01 | 0.619 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.404332e-01 | 0.619 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.404332e-01 | 0.619 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.404332e-01 | 0.619 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.404658e-01 | 0.619 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.440698e-01 | 0.612 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.462944e-01 | 0.609 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.462944e-01 | 0.609 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.487496e-01 | 0.604 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.569754e-01 | 0.590 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.569754e-01 | 0.590 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.569754e-01 | 0.590 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.569754e-01 | 0.590 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.569754e-01 | 0.590 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.569754e-01 | 0.590 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 2.569754e-01 | 0.590 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.620462e-01 | 0.582 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.644514e-01 | 0.578 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.651116e-01 | 0.577 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.651116e-01 | 0.577 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.651116e-01 | 0.577 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 2.651116e-01 | 0.577 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.664661e-01 | 0.574 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.724418e-01 | 0.565 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.727204e-01 | 0.564 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.731592e-01 | 0.564 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.731592e-01 | 0.564 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.731592e-01 | 0.564 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.764960e-01 | 0.558 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.787017e-01 | 0.555 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.805490e-01 | 0.552 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.811192e-01 | 0.551 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.811192e-01 | 0.551 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.811192e-01 | 0.551 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.811192e-01 | 0.551 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 2.811192e-01 | 0.551 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.811192e-01 | 0.551 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.886496e-01 | 0.540 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.887155e-01 | 0.540 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.889925e-01 | 0.539 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.889925e-01 | 0.539 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.889925e-01 | 0.539 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.889925e-01 | 0.539 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.889925e-01 | 0.539 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.889925e-01 | 0.539 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.905956e-01 | 0.537 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.905956e-01 | 0.537 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.905956e-01 | 0.537 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.935753e-01 | 0.532 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.967401e-01 | 0.528 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.967801e-01 | 0.528 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.967801e-01 | 0.528 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.967801e-01 | 0.528 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.967801e-01 | 0.528 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.044829e-01 | 0.516 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.044829e-01 | 0.516 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 3.044829e-01 | 0.516 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.048171e-01 | 0.516 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.058871e-01 | 0.514 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.088496e-01 | 0.510 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 3.088496e-01 | 0.510 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.121017e-01 | 0.506 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.121017e-01 | 0.506 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.121017e-01 | 0.506 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.121017e-01 | 0.506 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.121017e-01 | 0.506 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.121017e-01 | 0.506 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 3.121017e-01 | 0.506 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.169004e-01 | 0.499 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 3.169004e-01 | 0.499 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.196376e-01 | 0.495 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.196376e-01 | 0.495 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.196376e-01 | 0.495 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.196376e-01 | 0.495 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.196376e-01 | 0.495 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.270913e-01 | 0.485 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.270913e-01 | 0.485 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.270913e-01 | 0.485 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.270913e-01 | 0.485 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.270913e-01 | 0.485 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 3.289359e-01 | 0.483 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.289359e-01 | 0.483 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.344639e-01 | 0.476 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.344639e-01 | 0.476 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 3.344639e-01 | 0.476 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.344639e-01 | 0.476 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.409140e-01 | 0.467 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.409140e-01 | 0.467 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.417561e-01 | 0.466 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.417561e-01 | 0.466 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.429984e-01 | 0.465 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.448924e-01 | 0.462 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.473831e-01 | 0.459 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.489689e-01 | 0.457 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.489689e-01 | 0.457 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.489689e-01 | 0.457 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.489689e-01 | 0.457 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.489689e-01 | 0.457 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.489689e-01 | 0.457 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.489689e-01 | 0.457 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.489689e-01 | 0.457 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.489689e-01 | 0.457 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.489689e-01 | 0.457 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.489689e-01 | 0.457 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.503703e-01 | 0.455 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.528258e-01 | 0.452 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.533561e-01 | 0.452 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.561031e-01 | 0.448 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.561031e-01 | 0.448 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.561031e-01 | 0.448 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.561031e-01 | 0.448 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.561031e-01 | 0.448 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 3.561031e-01 | 0.448 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.607261e-01 | 0.443 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.607261e-01 | 0.443 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 3.607930e-01 | 0.443 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.631595e-01 | 0.440 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.631595e-01 | 0.440 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.631595e-01 | 0.440 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.631595e-01 | 0.440 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.631595e-01 | 0.440 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 3.631595e-01 | 0.440 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 3.682587e-01 | 0.434 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.685909e-01 | 0.433 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.701391e-01 | 0.432 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.701391e-01 | 0.432 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.701391e-01 | 0.432 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.701391e-01 | 0.432 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.770425e-01 | 0.424 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.770425e-01 | 0.424 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.770425e-01 | 0.424 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.770425e-01 | 0.424 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.770425e-01 | 0.424 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.770425e-01 | 0.424 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.770425e-01 | 0.424 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.803168e-01 | 0.420 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.831030e-01 | 0.417 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.838708e-01 | 0.416 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.838708e-01 | 0.416 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.838708e-01 | 0.416 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.838708e-01 | 0.416 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.838708e-01 | 0.416 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.838708e-01 | 0.416 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 3.838708e-01 | 0.416 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.880836e-01 | 0.411 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.880836e-01 | 0.411 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.906246e-01 | 0.408 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.973048e-01 | 0.401 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.973048e-01 | 0.401 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.973048e-01 | 0.401 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.973048e-01 | 0.401 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.973048e-01 | 0.401 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.973048e-01 | 0.401 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.973048e-01 | 0.401 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.034874e-01 | 0.394 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.039121e-01 | 0.394 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.039121e-01 | 0.394 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.039121e-01 | 0.394 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.039121e-01 | 0.394 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.039121e-01 | 0.394 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.039121e-01 | 0.394 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.039121e-01 | 0.394 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.039121e-01 | 0.394 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.039121e-01 | 0.394 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.039121e-01 | 0.394 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.039121e-01 | 0.394 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.060765e-01 | 0.391 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.104475e-01 | 0.387 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.104475e-01 | 0.387 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.104475e-01 | 0.387 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.104475e-01 | 0.387 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.104475e-01 | 0.387 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.125698e-01 | 0.385 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.149198e-01 | 0.382 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.169116e-01 | 0.380 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.169116e-01 | 0.380 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.169116e-01 | 0.380 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.169116e-01 | 0.380 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.212943e-01 | 0.375 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.224810e-01 | 0.374 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.224810e-01 | 0.374 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.233052e-01 | 0.373 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.233052e-01 | 0.373 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.233052e-01 | 0.373 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.299920e-01 | 0.367 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.358840e-01 | 0.361 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.358840e-01 | 0.361 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.358840e-01 | 0.361 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.358840e-01 | 0.361 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.358840e-01 | 0.361 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.358840e-01 | 0.361 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.420707e-01 | 0.355 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.420707e-01 | 0.355 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.420707e-01 | 0.355 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.420707e-01 | 0.355 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.420707e-01 | 0.355 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.420707e-01 | 0.355 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 4.420707e-01 | 0.355 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.448585e-01 | 0.352 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.481900e-01 | 0.349 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.481900e-01 | 0.349 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.481900e-01 | 0.349 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.485417e-01 | 0.348 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.542425e-01 | 0.343 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 4.602290e-01 | 0.337 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.661502e-01 | 0.331 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.661502e-01 | 0.331 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 4.661502e-01 | 0.331 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.661502e-01 | 0.331 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.661502e-01 | 0.331 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.720068e-01 | 0.326 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 4.725004e-01 | 0.326 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.777995e-01 | 0.321 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.777995e-01 | 0.321 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.835290e-01 | 0.316 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.835290e-01 | 0.316 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.835290e-01 | 0.316 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.835290e-01 | 0.316 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.835290e-01 | 0.316 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.835290e-01 | 0.316 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.835290e-01 | 0.316 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.891960e-01 | 0.311 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.891960e-01 | 0.311 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.891960e-01 | 0.311 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.003452e-01 | 0.301 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.003452e-01 | 0.301 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.058287e-01 | 0.296 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.058287e-01 | 0.296 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.112524e-01 | 0.291 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.166168e-01 | 0.287 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 5.167748e-01 | 0.287 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.219228e-01 | 0.282 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.219228e-01 | 0.282 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.219228e-01 | 0.282 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.219228e-01 | 0.282 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.219228e-01 | 0.282 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.259037e-01 | 0.279 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.271708e-01 | 0.278 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.271708e-01 | 0.278 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.271708e-01 | 0.278 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.323615e-01 | 0.274 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.323615e-01 | 0.274 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.323615e-01 | 0.274 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.323615e-01 | 0.274 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.323615e-01 | 0.274 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.325691e-01 | 0.274 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.374955e-01 | 0.270 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 5.380263e-01 | 0.269 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 5.424476e-01 | 0.266 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.425735e-01 | 0.266 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.425735e-01 | 0.266 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.425735e-01 | 0.266 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.457084e-01 | 0.263 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.475961e-01 | 0.262 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.525638e-01 | 0.258 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 5.569030e-01 | 0.254 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.585897e-01 | 0.253 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.623371e-01 | 0.250 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.638329e-01 | 0.249 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.671439e-01 | 0.246 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.671439e-01 | 0.246 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.714040e-01 | 0.243 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.743254e-01 | 0.241 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.766004e-01 | 0.239 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.766004e-01 | 0.239 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.766004e-01 | 0.239 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.805052e-01 | 0.236 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.812514e-01 | 0.236 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.812514e-01 | 0.236 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.812514e-01 | 0.236 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 5.812514e-01 | 0.236 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.904015e-01 | 0.229 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.904015e-01 | 0.229 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.904015e-01 | 0.229 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 5.912776e-01 | 0.228 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.949017e-01 | 0.226 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.949017e-01 | 0.226 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.993527e-01 | 0.222 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.993527e-01 | 0.222 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.037551e-01 | 0.219 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.037551e-01 | 0.219 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 6.056506e-01 | 0.218 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.081094e-01 | 0.216 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.124161e-01 | 0.213 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.124161e-01 | 0.213 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.208888e-01 | 0.207 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.208888e-01 | 0.207 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.291774e-01 | 0.201 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.291774e-01 | 0.201 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.332538e-01 | 0.198 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.372857e-01 | 0.196 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.372857e-01 | 0.196 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.412735e-01 | 0.193 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.469654e-01 | 0.189 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.491189e-01 | 0.188 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 6.491189e-01 | 0.188 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.507452e-01 | 0.187 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.605680e-01 | 0.180 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.730172e-01 | 0.172 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.823638e-01 | 0.166 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 6.858586e-01 | 0.164 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.927339e-01 | 0.159 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.961152e-01 | 0.157 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.994596e-01 | 0.155 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.092746e-01 | 0.149 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.124749e-01 | 0.147 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 7.156402e-01 | 0.145 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.187708e-01 | 0.143 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.218672e-01 | 0.142 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.249297e-01 | 0.140 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.309543e-01 | 0.136 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.339173e-01 | 0.134 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.368478e-01 | 0.133 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.442634e-01 | 0.128 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.454481e-01 | 0.128 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.482523e-01 | 0.126 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.544288e-01 | 0.122 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.564820e-01 | 0.121 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 7.604886e-01 | 0.119 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.644441e-01 | 0.117 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.721473e-01 | 0.112 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 7.737231e-01 | 0.111 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.746589e-01 | 0.111 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.795999e-01 | 0.108 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.820299e-01 | 0.107 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.027348e-01 | 0.095 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 8.049110e-01 | 0.094 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.049110e-01 | 0.094 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.154393e-01 | 0.089 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 8.194906e-01 | 0.086 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.310096e-01 | 0.080 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.352107e-01 | 0.078 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.413507e-01 | 0.075 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 8.437523e-01 | 0.074 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.568273e-01 | 0.067 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.706513e-01 | 0.060 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.893059e-01 | 0.051 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.926288e-01 | 0.049 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 8.964575e-01 | 0.047 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.143206e-01 | 0.039 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.180569e-01 | 0.037 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.283649e-01 | 0.032 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.633458e-01 | 0.016 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.769826e-01 | 0.010 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.860457e-01 | 0.006 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.883757e-01 | 0.005 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.901608e-01 | 0.004 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.904883e-01 | 0.004 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.915036e-01 | 0.004 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.915036e-01 | 0.004 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.977183e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.984808e-01 | 0.001 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.989248e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999948e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999995e-01 | 0.000 | 0 | 0 |